While the five biotech stocks highlighted in today’s article are a mix of large-cap leaders in the space and small-cap companies with massive upside potential, they are all best suited for aggressive growth accounts with a higher risk tolerance. For these five biotech stocks that have been identified by RBC as top picks – including one firm with a potential coronavirus treatment and other firms that RBC believes have “gigantic upside” beyond coronavirus – CLICK HERE.